From: Role of IL-22 in persistent allergic airway diseases caused by house dust mite: a pilot study
Patients with allergic airway diseases (N = 31) | Control group (n = 9) | ||
---|---|---|---|
Patients with allergic rhinitis (N = 22) | Patients with allergic rhinitis and allergic asthma (N = 9) | ||
Male/female, N | 10/12 | 4/5 | 2/7 |
Age, years, mean ± SEM | 27.27 ± 1.54 | 29.44 ± 2.99 | 34.33 ± 4.71 |
Duration of rhinitis symptoms, years, mean ± SEM | 13.33 ± 1.89 | 16.00 ± 3.84 | N/A |
Duration of asthma symptoms, years, mean ± SEM | N/A | 11.20 ± 5.90 | N/A |
Hypersensitivity to other aeroallergens, N (%) | 15 (75.00) | 7 (77.80) | N/A |
TNSS, mean ± SEM | 4.32 ± 0.55 | 3.88 ± 0.74 | N/A |
ACT, mean ± SEM | N/A | 19.5 ± 1.10 | N/A |
RQLQ, mean ± SEM | 1.61 ± 0.24 | 1.48 ± 0.50 | N/A |
AQLQ, mean ± SEM | N/A | 5.62 ± 0.40 | N/A |
PSQI, mean ± SEM | 7.05 ± 0.76 | 6.50 ± 1.64 | 5.67 ± 0.62 |